ACTIVE PHARMACEUTICAL INGREDIENTS |
|
|
API's |
CATEGORY |
Duloxetine HCL |
Anti-depressant |
Levetiracetam |
Anti-epileptic |
Sevelamer HCL |
Anti-hyperphosphatemic (Phosphate binding agent) |
Colesevelam HCL |
Anti-lipemic (Cholestrol-lowering Bile Acid Sequestrant) |
Felbamate |
Anti-convulsant |
Topiramate |
Anti-convulsant, Anti-migraine |
Mesalamine |
Anti-inflammatory (Gastrointensinal) |
Telmisartan |
Anti-hypertensives |
Valsartan |
Anti-hypertensives |
Sertaconazole |
Preparations for vaginal conditions |
Eslicarbazepine |
Epilepsy |
Etodolac |
Anti-inflammatory, Analgesic |
Hydrochlorothiazide |
Diuretics |
Mesalamine/Mesalazine |
Anti-inflammatory |
Lamotrigine |
Anti-convulsants |
Tramadol |
Anti-pyretics, Analgesic |
Irbesartan |
Anti-hypertensives |
Oxymetazoline Hydrochloride |
Topical Nasopharyngeal |
Xylometazoline Hydrochloride |
Topical Nasopharyngeal |
Topiramate |
Anti-convulsants |
Phenylphrine Base |
Decongestant |
Oxcarbazepine |
Anti-convulsants |
Acetazolamide |
Diuretic |
Bendroflumethiazide |
Diuretic |
Mtoprolol Tartrate |
Anti-hypertensives |
Metoprolol Succinate |
Anti-hypertensives |
Metoprolol Tartrate |
Anti-hypertensives |
Metoprolol Tartrate (Route-I) |
Anti-hypertensives |
Amiodarone Hydrochloride |
Anti-arrhythmics |
Carbamazepine |
Anti-convulsants |
Chlorothiazide |
Diuretic, Anti-hypertensives |
Carvedilol |
Anti-hypertensives |
Terazosin Hydrochloride Dihydrate |
Anti-hypertensives |
Alendronate Sodium |
Anti-osteoporotic, Antipagetic |
Lamotrigine |
Anti-convulsant |
Irbesartan |
Anti-hypertensives |
Terbinafine Hydrochloride |
Anti-fungal |
Felbinac |
Anti-inflammatory, Analgesic |
Hydrated Dihhydralazine Sulfate |
Anti-hypertensives |
Ondansetron Hydrochloride |
Anti-emetic |
Olmesartan |
Anti-hypertensives |
Pregabalin |
Anti-convulsant, Anxiolytic, Analgesic |
|
|
|
|
|
Address |
A-35, M.I.D.C. Malegaon, Sinnar, Dist. Nashik - 422103, Maharashtra, India. |
Cell No. |
+91 9167041905 / +91 9920063173 (India)
+44 74518 44580 (UK) |
Email |
|
................................................................ |
|
|
|